usion, to
decrease blood use, and to lower costs, a recent Cochrane
analysis supported more restrictive guidelines for all patients, including those with cardiovascular disease.625
Therefore, on the basis of currently available evidence, in
the absence of ongoing blood loss, transfusion during or
after OSR or EVAR is recommended only if the hemoglobin
concentration is at or below 7 g/dL.
In the absence of ongoing blood loss, we suggest a